像兄弟你分析的一样，$BioNTech(BNTX)$ 在3季度的财务报告资料里特意说了现金等价物只有24亿欧元的事情，主要是因为大部分$辉瑞(PFE)$ 的应收款（应收帐款总额106亿欧元，大部分是辉瑞的未结算款项），在10月会收到相关款项。

如果加上这106亿欧元，现金一共会有130亿欧元，折合美元147亿美元。

Cash Position: Cash and cash equivalents as of September 30, 2021 were €2,392.7 million. In addition, trade receivables remained outstanding which is mainly due to the contractual settlement of the gross profit share under the COVID-19 collaboration with Pfizer, which has a temporal offset of more than one calendar quarter. As Pfizer’s fiscal quarter for subsidiaries outside the United States differs from BioNTech’s financial reporting cycle, it creates an additional time lag between the recognition of revenues and the payment receipt. Consequently, these trade receivables which are subject to this temporal offset and were outstanding as of September 30, 2021 were received as payments in October 2021, improving BioNTech’s cash position.查看图片